At a glance
- Originator Medivir AB
- Class Antivirals; Small molecules
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 28 May 2001 Discontinued-Preclinical for HIV infections treatment in USA (Unknown route)
- 10 Sep 1998 No-Development-Reported for HIV infections treatment in USA (Unknown route)
- 29 Aug 1996 New profile